PTIX
Protagenic Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website rotagenic.com
- Employees(FY) -
- ISIN US74365N2027
Performance
+16.29%
1W
+11.12%
1M
+50.03%
3M
+85.2%
6M
+51.53%
YTD
-24.62%
1Y
Profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Technical Analysis of PTIX 2024-05-10
Overview:
In analyzing the technical indicators for PTIX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-04-30 20:38
- 2024-04-16 20:42
- 2024-04-01 09:53
- 2024-04-01 04:20
- 2024-03-26 20:42
- 2024-03-25 05:00
- 2024-03-20 20:41
- 2024-02-12 19:30
- 2023-12-11 18:30
- 2023-10-12 21:00
- 2023-09-25 20:18
- 2023-03-22 00:55
- 2022-04-25 20:15
- 2021-11-15 20:58
- 2021-08-29 21:15
- 2021-08-16 19:45
- 2021-07-23 04:21
- 2021-07-07 23:20
- 2021-07-05 18:17
- 2021-06-22 21:35
- 2021-06-15 21:15
- 2021-04-29 03:06
- 2021-04-26 08:58
- 2020-12-15 20:15
- 2020-09-08 00:10
Page 1 of 1
previousnext